1 |
Fujii T, Takayasu K, Muramatsu Y, et al. Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis[J]. Jpn J Clin Oncol, 1993,23(2):105-109.
|
2 |
Portolani N, Coniglio A, Ghidoni S, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications[J]. Ann Surg, 2006,243(2):229-235.
|
3 |
Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey[J]. Cancer, 2004,101(4):796-802.
|
4 |
Yoshidome H, Takeuchi D, Kimura F, et al. Treatment strategy for hepatocellular carcinoma with major portal vein or inferior vena cava invasion: a single institution experience[J]. J Am Coll Surg, 2011,212(5):796-803.
|
5 |
Gabibbo G, Enea M, Attanasio M, et al. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma[J]. Hepatology, 2010,51(4):1274-1283.
|
6 |
Niguma T, Mimura T, Tutui N. Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study[J]. J Hepatobiliary Pancreat Surg, 2005,12(3):249-253.
|
7 |
Shi J, Lai E C H, Li N, et al. A new classification for hepatocellular carcinoma with portal vein tumor thrombus[J]. J Hepatobiliary Pancreat Sci, 2011,18(1):74-80.
|
8 |
Shuqun C, Mengchao W, Han C, et al. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein[J]. Hepatogastroenterology, 2007,74(74):499-502.
|
9 |
Ando E, Tanaka M, Yamashita F, et al. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases[J]. Cancer, 2002,95(3):588-595.
|
10 |
Yamada R, Sato M, Kawabata M, et al. Hepatic artery embolization in 120 patients with unresectable hepatoma[J]. Radiology, 1983,148(2):397-401.
|
11 |
Jeon SH, Park KS, Kim YH, et al. Incidence and risk factors of acute hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. Korean J Gastroenterol, 2007,50(3):176-82.
|
12 |
Llovet JM, Real MI, Montaña X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial[J]. Lancet, 2002, 359(9319):1734-1739.
|
13 |
Carr BI, Irish W, Federle MP. Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis[J]. Hepatogastroenterology, 2010,57(104):1375-1381.
|
14 |
Georgiades C S, Hong K, D'Angelo M, et al. Safety and efficacy of transarterial chemoembolization in patients with unresectable hepatocellular carcinoma and portal vein thrombosis[J]. J Vasc Interv Radiol, 2005,16(12):1653-1659.
|
15 |
Luo J, Guo RP, Lai EC, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study[J]. Ann Surg Oncol, 2011,18(2):413-420.
|
16 |
Fukuda S, Okuda K, Imamura M, et al. Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases[J]. Surgery, 2002,131(3):300-310.
|
17 |
茅国新,于志坚,等.经导管肝动脉和B超引导下经细针门静脉双重化疗栓塞治疗原发性肝癌[J]. 中华肿瘤杂志, 2002,24(4):391-393.
|
18 |
程树群,李楠,吴孟超.门静脉癌栓分型与治疗选择[J]. 中国普外基础与临床杂志,2012,19(3):240-242.
|
19 |
Kim K M, Kim J H, Park I S, et al. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion[J]. J Gastroenterol Hepatol, 2009,24(5):806-814.
|
20 |
Yamakado K, Tanaka N, Nakatsuka A, et al. Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein[J]. J Hepatol, 1999,30(4):660-668.
|
21 |
张磊,陆骊工,李勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J]. 介入放射学杂志, 2011,20(12):968-973.
|
22 |
张曦彤,徐克,张汉国,等.原发性肝癌伴门脉高压的TIPSS治疗[J]. 临床放射学杂志,1995,14(4):236-238.
|
23 |
Yamagami T, Nakamura T, Tanaka O, et al. Transjugular Intrahepatic Portosystemic Shunt after Complete Obstruction of Portal Vein[J]. J Vasc Interv Radiol, 1999,10(5):575-578.
|
24 |
Zhao JB, Feng C, Zhu QH, et al. Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis[J]. World J Gastroenterol, 2014,20(6):1602-1607.
|
25 |
Livraghi T, Grigioni W, Mazziotti A, et al. Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma: a new possible treatment[J]. Tumori, 1990,76(4):394-397.
|
26 |
张秀娟,林礼务,薛恩生,等.超声引导经皮无水乙醇注射治疗肝癌伴发门静脉癌栓[J].中国介入影像与治疗学, 2011,8(5):367-370.
|
27 |
陆正华,沈锋,杨家和,等. 经皮激光消融治疗肝癌门静脉癌栓[J].中国微创外科杂志,2007,7(4):331-333.
|
28 |
Giorgio A, Di Sarno A, De Stefano G, et al. Hepatocellular carcinoma with cirrhosis: are patients with neoplastic main portal vein invasion eligible for percutaneous radiofrequency ablation of both the nodule and the portal venous tumor thrombus? AJR Am J Roentgenol[J], 2009,193(4):948-954.
|
29 |
葛乃建,杨业发,申淑群,等.经皮穿刺射频消融治疗门静脉癌栓15例[J]. 介入放射学杂志, 2014,23(10):883-886.
|
30 |
Orsi F, Arnone P, Chen W, et al. High intensity focused ultrasound ablation: a new therapeutic option for solid tumors[J]. J Cancer Res Ther, 2010,6(4):414-420.
|
31 |
朱辉,陈文直,黎克全,等.超声引导药物注射结合高强度聚焦超声治疗门静脉癌栓的初步临床观察[J].中国超声医学杂志,2004,20(1):73-75.
|
32 |
Huang H, Chen KC. Preliminary clinical observation of high intensity focused ultrasound in treatment of embolization in portal vein[J]. J Mod Oncol, 2006,14(9):1116-1118.
|
33 |
Marelli L, Shusang V, Buscombe JR, et al. Transarterial injection of 131I-Lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer[J]. J Nucl Med, 2009,50(6):871-877.
|
34 |
林俊清,杨维竹,江娜, 等. CT引导下125I放射性粒子植入治疗原发性肝细胞癌伴门静脉癌栓[J].中国介入影像与治疗学,2011,8(4):299-302.
|
35 |
Luo J, Yan Z, Liu Q, et al. Endovascular placement of iodine-125 seed strand and stent combined with chemoembolization for treatment of hepatocellular carcinoma with tumor thrombus in main portal vein[J]. J Vasc Interv Radiol, 2011,22(4):479-489.
|